The effect of atorvastatin on lung histopathology in a murine model of chronic asthma

Allergologia et Immunopathologia

Volumn 42, Issue 4, 2014, Pages 355-361

  Firinci, Fatih ^a   Karaman, Meral ^a   Cilaker Micili, Serap ^a   Bagriyanik, Alper ^a   Uzuner, Nevin ^a   Karaman, Özkan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Asthma; Atorvastatin; Mice

Indexed keywords

ATOR; ATORVASTATIN; DEXAMETHASONE; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; PLACEBO; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BASEMENT MEMBRANE; CELL COUNT; DRUG EFFICACY; ELECTRON MICROSCOPY; GOBLET CELL; HISTOPATHOLOGY; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; SMOOTH MUSCLE; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECTS; LUNG; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICHOLESTEREMIC AGENTS; ASTHMA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEPTANOIC ACIDS; LUNG; MALE; MICE; MICE, INBRED BALB C; PYRROLES;

EID: 84903820224     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2013.09.002     Document Type: Article

References (36)

1. Hansel T.T., Barnes P.J. Novel drugs for treating asthma. Curr Allergy Asthma Rep 2001, 1:164-173.
2. Kumar R.K. Understanding airway wall remodeling in asthma: a basis for improvements in therapy?. Pharmacol Ther 2001, 91:93-104.
3. Tagaya E., Tamaoki J. Mechanisms of airway remodeling in asthma. Allergol Int 2007, 56:33-40.
4. Sumi Y., Hamid Q. Airway remodeling in asthma. Allergol Int 2007, 56:341-348.
5. Payne D.N., Rogers A.V., Adelroth E., Bandi V., Guntupalli K.K., Bush A., et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003, 167:78-82.
6. Liao J.K., Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005, 45:89-118.
7. Kwak B., Mulhaupt F., Myit S., Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000, 6:1399e1402.
8. Tristano A.G., Fuller K. Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved. Int Immunopharmacol 2006, 6(December (12)):1833-1846.
9. Chiba Y., Sato S., Misawa M. Inhibition of antigen-induced bronchial smooth muscle hyperresponsiveness by lovastatin in mice. J Smooth Muscle Res 2008, 44:123e128.
10. Xu L., Dong X.W., Shen L.L., Li F.F., Jiang J.X., Cao R., et al. Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma. Int Immunopharmacol 2012, 12:556e564.
11. Temelkovski J., Hogan S.P., Shepherd D.P., Foster P.S., Kumar R.K., et al. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methocholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998, 53:849-856.
12. Firinci F., Karaman M., Baran Y., Bagriyanik A., Ayyildiz Z.A., Kiray M., et al. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011, 11:1120-1126.
13. Melo A.C., Valenca S.S., Gitirana L.B., Santos J.C., Ribeiro M.L., Machado M.N., et al. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. Int Immunopharmacol 2013.
14. Karaman M., Firinci F., Kiray M., Tuncel T., Bagriyanik A., Yilmaz O., et al. Beneficial effects of erythropoietin on airway histology in a murine model of chronic asthma. Allergol Immunopathol (Madr) 2012, 40:75-80.
15. Panettieri R.A. Airway smooth muscle: an immunomodulatory cell. J Allergy Clin Immunol 2002, 110:269-274.
16. Koumoundouros E., Bischof R.J., Meeusen E.N., Mareels I.M., Snibson K.J., et al. Chronic airway disease: deteriorating pulmonary function in sheep associated with repeated challenges of house dust mite. Exp Lung Res 2006, 32:321-330.
17. Schaafsma D., Dueck G., Ghavami S., Kroeker A., Mutawe M.M., Hauff K., et al. The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle. Am J Respir Cell Mol Biol 2011, 44:394-403.
18. Pennings H.J., Kramer K., Bast A., Buurman W.A., Wouters E.F., et al. Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. Eur Respir J 1998, 12:45-49.
19. Câmara J., Jarai G. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis Tissue Repair 2010, 3:2.
20. Simes J., Furberg C.D., Braunwald E., Davis B.R., Ford I., Tonkin A., et al. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J 2002, 23:207-215.
21. Kwak B., Mulhaupt F., Myit S., Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000, 6:1399-1402.
22. Shyu K.G., Chua S.K., Wang B.W., Kuan P. Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-alpha in macrophages. J Biomed Sci 2009, 27:50.
23. Awad A.S., El Sharif A. Immunomodulatory effects of rosuvastatin on hepatic ischemia/reperfusion induced injury. Immunopharmacol Immunotoxicol 2010, 32:555-561.
24. Kim D.Y., Ryu S.Y., Lim J.E., Lee Y.S., Ro J.Y. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 2007, 14:76-86.
25. McKay A., Leung B.P., McInnes I.B., Thomson N.C., Liew F.Y. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 2004, 172:2903-2908.
26. Zeki A.A., Franzi L., Last J., Kenyon N.J. Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med 2009, 15:731-740.
27. Zeki A.A., Bratt J.M., Rabowsky M., Last J.A., Kenyon N.J. Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?. Transl Res 2010, 156:335-349.
28. Imamura M., Okunishi K., Ohtsu H., Nakagome K., Harada H., Tanaka R. Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung. Thorax 2009, 64:44-49.
29. Egesi A., Sun G., Khachemoune A., Rashid R.M. Statins in skin: research and rediscovery, from psoriasis to sclerosis. J Drugs Dermatol 2010, 9:921-927.
30. Queralt M., Brazis P., Merlos M., De Mora F., Puigdemont A. In vitro inhibitory effect of rupatadine on histamine and TNF-a release from dispersed canine skin mast cells and the human mast cell line HMC-1. Inflamm Res 2000, 49:355-360.
31. Lin C.C., Lin C.Y. Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration. J Asthma 1997, 34:153-160.
32. Cuss F.M., Dixon C.M., Barnes P.J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986, 26:189-192.
33. Kishimoto S., Shimadzu W., Izumi T., Shimizu T., Sagara H., Fukuda T., et al. Comparison of platelet-activating factor receptor mRNA levels in peripheral blood eosinophils from normal subjects and atopic asthmatic patients. Int Arch Allergy Immunol 1997, 114(Suppl. 1):60-63.
34. Chan-Yeung M., Lam S., Chan H., Tse K.S., Salari H. The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction. J Allergy Clin Immunol 1991, 87:667-673.
35. Tsantila N., Tsoupras A.B., Fragopoulou E., Antonopoulou S., Iatrou C., Demopoulos C.A. In vitro and in vivo effects of statins on platelet-activating factor and its metabolism. Angiology 2011, 62:209-218.
36. Cowan D.C., Cowan J.O., Palmay R., Williamson A., Taylor D.R. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 2010, 65:891-896.